Hwaseong-si, South Korea

Yu Yon Kim

This inventor holds 1 USPTO granted patent. Top assignee: Hanmi Pharm. Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yu Yon Kim. Retrieved from https://idiyas.com/inventor/yu-yon-kim-beeds7l1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yu Yon Kim: Innovator in Immune-Stimulating Therapies

Introduction

Yu Yon Kim is a prominent inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of immunology through his innovative research and development efforts. His work focuses on creating novel therapeutic solutions that enhance immune responses.

Latest Patents

Yu Yon Kim holds a patent for a "Novel Conjugate of Immune-Stimulating IL-2 Analog and Preparation Method Thereof." This patent represents a breakthrough in the development of immune-stimulating therapies, showcasing his expertise and commitment to advancing medical science. He has 1 patent to his name.

Career Highlights

Kim is currently employed at Hanmi Pharmaceutical Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His role at the company allows him to collaborate with other talented professionals in the industry, contributing to the development of cutting-edge therapies.

Collaborations

Throughout his career, Yu Yon Kim has worked alongside notable colleagues, including Yong Ho Heo and Euh Lim Oh. These collaborations have fostered a dynamic environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Yu Yon Kim is a dedicated inventor whose work in immune-stimulating therapies is paving the way for future medical advancements. His contributions to the field are invaluable, and his ongoing research promises to enhance therapeutic options for patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…